16. Urologische aandoeningen

go back to reference Arndt UP, Koningsbruggen PJW van, Salden NMA, Visser HS van der, Wal J, Lieshout J van. NHG-Standaard Urinesteenlijden; 2007. Beschikbaar via:www.nhg.artsennet.nl. Arndt UP, Koningsbruggen PJW van, Salden NMA, Visser HS van der, Wal J, Lieshout J van. NHG-Standaard Urinesteenlijden; 2007. Beschikbaar via:www.​nhg.​artsennet.​nl.​

go back to reference AUA practice guidelines committee. AUA guideline on the management of benign prostatic hyperplasia. Diagnosis and treatment recommendations. Beschikbaar via:www.auanet.org/content/clinical-practice-guidelines. AUA practice guidelines committee. AUA guideline on the management of benign prostatic hyperplasia. Diagnosis and treatment recommendations. Beschikbaar via:www.​auanet.​org/​content/​clinical-practice-guidelines.​

go back to reference Bangma, CH (red.). Urologie. Houten: Bohn Stafleu van Loghum; 2008. Bangma, CH (red.). Urologie. Houten: Bohn Stafleu van Loghum; 2008.

go back to reference Djavan B, Marberger M. A meta analyses on the efficacy and tolerability of a-1 adrenoceptor antagonists in patients with lower urinary tract symptoms suggestive of benign prostatic obstruction. Eur Urol 1999;36:1–13.PubMedCrossRef Djavan B, Marberger M. A meta analyses on the efficacy and tolerability of a-1 adrenoceptor antagonists in patients with lower urinary tract symptoms suggestive of benign prostatic obstruction. Eur Urol 1999;36:1–13.PubMedCrossRef

go back to reference EAU Guidelines 2011 Benign prostatic hyperplasia. Non-neurogenic male LUTS. Beschikbaar via:www.uroweb.org/gls/pdf/12_Male_LUTS.pdf. EAU Guidelines 2011 Benign prostatic hyperplasia. Non-neurogenic male LUTS. Beschikbaar via:www.​uroweb.​org/​gls/​pdf/​12_​Male_​LUTS.​pdf.​

go back to reference Haaren KAM van, Visser HS, Vliet S van, Timmermans AE, Yadava R, Geerlings SE, et al. NHG-Standaard Urineweginfecties; 2005. Beschikbaar via:www.nhg.artsennet.nl. Haaren KAM van, Visser HS, Vliet S van, Timmermans AE, Yadava R, Geerlings SE, et al. NHG-Standaard Urineweginfecties; 2005. Beschikbaar via:www.​nhg.​artsennet.​nl.

go back to reference Marberger M, Harkaway R, Rosette J de la. Optimising the medical management of benign prostatic hyperplasia. Eur Urol 2004;43:411–9.CrossRef Marberger M, Harkaway R, Rosette J de la. Optimising the medical management of benign prostatic hyperplasia. Eur Urol 2004;43:411–9.CrossRef

go back to reference Nederlandse Vereniging voor Urologie. Richtlijn diagnostiek en therapie LUTS/BPH; 2006. Beschikbaar via:www.nvu.nl. Nederlandse Vereniging voor Urologie. Richtlijn diagnostiek en therapie LUTS/BPH; 2006. Beschikbaar via:www.​nvu.​nl.​

go back to reference NVVA. Richtlijn Urineweginfecties. Utrecht: NVVA; 2006. NVVA. Richtlijn Urineweginfecties. Utrecht: NVVA; 2006.

go back to reference Sarma A, Jacobson D, McGree M, Roberts RO, Lieber MM, Jacobsen SJ. A population based study of incidence and treatment of benign prostatic hyperplasia among residents of Olmsted county, Minnesota: 1987–1997. J Urol 2005;173:2048–53. Sarma A, Jacobson D, McGree M, Roberts RO, Lieber MM, Jacobsen SJ. A population based study of incidence and treatment of benign prostatic hyperplasia among residents of Olmsted county, Minnesota: 1987–1997. J Urol 2005;173:2048–53.

go back to reference V&VN, LEVV. Richtlijn Urine-incontinentie bij kwetsbare ouderen; 2010. Beschikbaar via:www.venvn.nl/LinkClick.aspx?fileticket=Yxcf468Hnrc%3D&tabid=1852. V&VN, LEVV. Richtlijn Urine-incontinentie bij kwetsbare ouderen; 2010. Beschikbaar via:www.​venvn.​nl/​LinkClick.​aspx?​fileticket=​Yxcf468Hnrc%3D&​tabid=​1852.​